Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua M Cohen

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Plastic and Reconstructive Surgery|February 2, 2023
Gender Considerations in RhinoplastyAbigail M Rodriguez, Ira L Savetsky, Joshua M Cohen, et al.
The Journal of Headache and Pain|April 17, 2021
Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlled trialEgilius L H Spierings, Mikko Kärppä, Xiaoping Ning, et al.
Plastic and Reconstructive Surgery. Global Open|October 30, 2023
Preauthorization Inconsistencies Prevail in Reduction MammaplastyCarter J Boyd, Kshipra Hemal, Joshua M Cohen, et al.
Journal of Clinical Medicine|August 12, 2022
Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive TreatmentsGeorge R Nissan, Richard Kim, Joshua M Cohen, et al.
Headache|September 2, 2017
Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive MedicinesJoshua M Cohen, David W Dodick, Ronghua Yang, et al.
The Journal of Headache and Pain|September 5, 2020
Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey studyDawn C Buse, Sanjay K Gandhi, Joshua M Cohen, et al.
The Journal of Headache and Pain|January 8, 2021
Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trialsStephen D Silberstein, Joshua M Cohen, Ronghua Yang, et al.
Neurology|September 11, 2020
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized studyPeter J Goadsby, Stephen D Silberstein, Paul P Yeung, et al.
Pain Management|June 9, 2021
PEARL study protocol: a real-world study of fremanezumab effectiveness in patients with chronic or episodic migraineMessoud Ashina, Faisal Mohammad Amin, Pinar Kokturk, et al.
The Journal of Headache and Pain|December 19, 2021
Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS studyAntoinette MaassenVanDenBrink, Gisela M Terwindt, Joshua M Cohen, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Plastic and Reconstructive Surgery|February 2, 2023
Gender Considerations in RhinoplastyAbigail M Rodriguez, Ira L Savetsky, Joshua M Cohen, et al.
The Journal of Headache and Pain|April 17, 2021
Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlled trialEgilius L H Spierings, Mikko Kärppä, Xiaoping Ning, et al.
Plastic and Reconstructive Surgery. Global Open|October 30, 2023
Preauthorization Inconsistencies Prevail in Reduction MammaplastyCarter J Boyd, Kshipra Hemal, Joshua M Cohen, et al.
Journal of Clinical Medicine|August 12, 2022
Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive TreatmentsGeorge R Nissan, Richard Kim, Joshua M Cohen, et al.
Headache|September 2, 2017
Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive MedicinesJoshua M Cohen, David W Dodick, Ronghua Yang, et al.
The Journal of Headache and Pain|September 5, 2020
Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey studyDawn C Buse, Sanjay K Gandhi, Joshua M Cohen, et al.
The Journal of Headache and Pain|January 8, 2021
Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trialsStephen D Silberstein, Joshua M Cohen, Ronghua Yang, et al.
Neurology|September 11, 2020
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized studyPeter J Goadsby, Stephen D Silberstein, Paul P Yeung, et al.
Pain Management|June 9, 2021
PEARL study protocol: a real-world study of fremanezumab effectiveness in patients with chronic or episodic migraineMessoud Ashina, Faisal Mohammad Amin, Pinar Kokturk, et al.
The Journal of Headache and Pain|December 19, 2021
Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS studyAntoinette MaassenVanDenBrink, Gisela M Terwindt, Joshua M Cohen, et al.
Pageof 8